{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:14Z","timestamp":1791928694568,"version":"4.3.4"},"reference-count":50,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"5","license":[{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2019,4,4]]},"DOI":"10.1167\/iovs.19-26560","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T16:34:08Z","timestamp":1554395648000},"page":"1442","source":"Crossref","is-referenced-by-count":17,"title":["A Mixture of U.S. Food and Drug Administration\u2013Approved Monoaminergic Drugs Protects the Retina From Light Damage in Diverse Models of Night Blindness"],"prefix":"10.1167","volume":"60","author":[{"given":"Henri","family":"Leinonen","sequence":"first","affiliation":[{"name":"Gavin Herbert Eye Institute and the Department of Ophthalmology, University of California-Irvine, Irvine, California, United States"},{"name":"Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot H.","family":"Choi","sequence":"additional","affiliation":[{"name":"Gavin Herbert Eye Institute and the Department of Ophthalmology, University of California-Irvine, Irvine, California, United States"},{"name":"Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Gardella","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, Ohio, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir J.","family":"Kefalov","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Washington University, St. Louis, Missouri, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Palczewski","sequence":"additional","affiliation":[{"name":"Gavin Herbert Eye Institute and the Department of Ophthalmology, University of California-Irvine, Irvine, California, United States"},{"name":"Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-60-5-1442-b01","unstructured":"World Health Organization. Global Data on Visual Impairment 2010. Geneva, Switzerland: World Health Organization; 2010."},{"key":"i1552-5783-60-5-1442-b02","doi-asserted-by":"crossref","unstructured":"de Jong PT. Age-related macular degeneration. N Engl J Med. 2006; 355: 1474\u20131485.","DOI":"10.1056\/NEJMra062326"},{"key":"i1552-5783-60-5-1442-b03","doi-asserted-by":"crossref","unstructured":"Cummings J. Disease modification and neuroprotection in neurodegenerative disorders. Transl Neurodegener. 2017; 6: 25.","DOI":"10.1186\/s40035-017-0096-2"},{"key":"i1552-5783-60-5-1442-b04","doi-asserted-by":"crossref","unstructured":"Chen Y, Palczewski K. Systems pharmacology links GPCRs with retinal degenerative disorders. Annu Rev Pharmacol Toxicol. 2016; 56: 273\u2013298.","DOI":"10.1146\/annurev-pharmtox-010715-103033"},{"key":"i1552-5783-60-5-1442-b05","doi-asserted-by":"crossref","unstructured":"Chen Y, Kern TS, Kiser PD, Palczewski K. Eyes on systems pharmacology. Pharmacol Res. 2016; 114: 39\u201341.","DOI":"10.1016\/j.phrs.2016.09.026"},{"key":"i1552-5783-60-5-1442-b06","doi-asserted-by":"crossref","unstructured":"Halls ML, Cooper DM. Regulation by Ca2+-signaling pathways of adenylyl cyclases. Cold Spring Harb Perspect Biol. 2011; 3: a004143.","DOI":"10.1101\/cshperspect.a004143"},{"key":"i1552-5783-60-5-1442-b07","doi-asserted-by":"crossref","unstructured":"Chen Y, Palczewska G, Masuho I, et al. Synergistically acting agonists and antagonists of G protein-coupled receptors prevent photoreceptor cell degeneration. Sci Signal. 2016; 9: ra74.","DOI":"10.1126\/scisignal.aag0245"},{"key":"i1552-5783-60-5-1442-b08","unstructured":"Rodieck RW. The First Steps in Seeing. Sunderland, MA: Sinauer Associates; 1998."},{"key":"i1552-5783-60-5-1442-b09","doi-asserted-by":"crossref","unstructured":"Palczewski K. G protein-coupled receptor rhodopsin. Annu Rev Biochem. 2006; 75: 743\u2013767.","DOI":"10.1146\/annurev.biochem.75.103004.142743"},{"key":"i1552-5783-60-5-1442-b10","doi-asserted-by":"crossref","unstructured":"Maeda T, Imanishi Y, Palczewski K. Rhodopsin phosphorylation: 30 years later. Prog Retin Eye Res. 2003; 22: 417\u2013434.","DOI":"10.1016\/S1350-9462(03)00017-X"},{"key":"i1552-5783-60-5-1442-b11","doi-asserted-by":"crossref","unstructured":"Chen Y, Palczewska G, Mustafi D, et al. Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration. J Clin Invest. 2013; 123: 5119\u20135134.","DOI":"10.1172\/JCI69076"},{"key":"i1552-5783-60-5-1442-b12","doi-asserted-by":"crossref","unstructured":"Orban T, Leinonen H, Getter T, et al. A combination of G protein-coupled receptor modulators protects photoreceptors from degeneration. J Pharmacol Exp Ther. 2018; 364: 207\u2013220.","DOI":"10.1124\/jpet.117.245167"},{"key":"i1552-5783-60-5-1442-b13","doi-asserted-by":"crossref","unstructured":"Naeem MA, Chavali VRM, Ali S, et al. GNAT1 associated with autosomal recessive congenital stationary night blindness. Invest Ophthalmol Vis Sci. 2012; 53: 1353\u20131361.","DOI":"10.1167\/iovs.11-8026"},{"key":"i1552-5783-60-5-1442-b14","doi-asserted-by":"crossref","unstructured":"Cideciyan AV, Zhao X, Nielsen L, Khani SC, Jacobson SG, Palczewski K. Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. Proc Natl Acad Sci U S A. 1998; 95: 328\u2013333.","DOI":"10.1073\/pnas.95.1.328"},{"key":"i1552-5783-60-5-1442-b15","doi-asserted-by":"crossref","unstructured":"Calvert PD, Krasnoperova NV, Lyubarsky AL, et al. Phototransduction in transgenic mice after targeted deletion of the rod transducin alpha-subunit. Proc Natl Acad Sci U S A. 2000; 97: 13913\u201313918.","DOI":"10.1073\/pnas.250478897"},{"key":"i1552-5783-60-5-1442-b16","doi-asserted-by":"crossref","unstructured":"Ronning KE, Allina GP, Miller EB, et al. Loss of cone function without degeneration in a novel Gnat2 knock-out mouse. Exp Eye Res. 2018; 171: 111\u2013118.","DOI":"10.1016\/j.exer.2018.02.024"},{"key":"i1552-5783-60-5-1442-b17","doi-asserted-by":"crossref","unstructured":"Frederiksen R, Nymark S, Kolesnikov AV, et al. Rhodopsin kinase and arrestin binding control the decay of photoactivated rhodopsin and dark adaptation of mouse rods. J Gen Physiol. 2016; 148: 1\u201311.","DOI":"10.1085\/jgp.201511538"},{"key":"i1552-5783-60-5-1442-b18","doi-asserted-by":"crossref","unstructured":"Chen CK, Burns ME, Spencer M, et al. Abnormal photoresponses and light-induced apoptosis in rods lacking rhodopsin kinase. Proc Natl Acad Sci U S A. 1999; 96: 3718\u20133722.","DOI":"10.1073\/pnas.96.7.3718"},{"key":"i1552-5783-60-5-1442-b19","doi-asserted-by":"crossref","unstructured":"Danciger M, Matthes MT, Yasamura D, et al. A QTL on distal chromosome 3 that influences the severity of light-induced damage to mouse photoreceptors. Mamm Genome. 2000; 11: 422\u2013427.","DOI":"10.1007\/s003350010081"},{"key":"i1552-5783-60-5-1442-b20","doi-asserted-by":"crossref","unstructured":"Nusinowitz S, Nguyen L, Radu R, Kashani Z, Farber D, Danciger M. Electroretinographic evidence for altered phototransduction gain and slowed recovery from photobleaches in albino mice with a MET450 variant in RPE65. Exp Eye Res. 2003; 77: 627\u2013638.","DOI":"10.1016\/S0014-4835(03)00217-3"},{"key":"i1552-5783-60-5-1442-b21","doi-asserted-by":"crossref","unstructured":"Bell BA, Kaul C, Bonilha VL, Rayborn ME, Shadrach K, Hollyfield JG. The BALB\/c mouse: effect of standard vivarium lighting on retinal pathology during aging. Exp Eye Res. 2015; 135: 192\u2013205.","DOI":"10.1016\/j.exer.2015.04.009"},{"key":"i1552-5783-60-5-1442-b22","doi-asserted-by":"crossref","unstructured":"Xu J, Dodd RL, Makino CL, Simon MI, Baylor DA, Chen J. Prolonged photoresponses in transgenic mouse rods lacking arrestin. Nature. 1997; 389: 505\u2013509.","DOI":"10.1038\/39068"},{"key":"i1552-5783-60-5-1442-b23","doi-asserted-by":"crossref","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016; 7: 27\u201331.","DOI":"10.4103\/0976-0105.177703"},{"key":"i1552-5783-60-5-1442-b24","doi-asserted-by":"crossref","unstructured":"Bengtsson C, Johnsson G, Regardh CG. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment. Clin Pharmacol Ther. 1975; 17: 400\u2013408.","DOI":"10.1002\/cpt1975174400"},{"key":"i1552-5783-60-5-1442-b25","doi-asserted-by":"crossref","unstructured":"Friis ML, Gron U, Larsen NE, Pakkenberg H, Hvidberg EF. Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease. Eur J Clin Pharmacol. 1979; 15: 275\u2013280.","DOI":"10.1007\/BF00618517"},{"key":"i1552-5783-60-5-1442-b26","unstructured":"Matsushima H, Kamimura H, Soeishi Y, Watanabe T, Higuchi S, Tsunoo M. Pharmacokinetics and plasma protein binding of tamsulosin hydrochloride in rats, dogs, and humans. Drug Metab Dispos. 1998; 26: 240\u2013245."},{"key":"i1552-5783-60-5-1442-b27","doi-asserted-by":"crossref","unstructured":"Carrigan M, Duignan E, Humphries P, Palfi A, Kenna PF, Ferrar GJ. A novel homozygous truncating GNAT1 mutation implicated in retinal degeneration. Br J Ophthalmol. 2016; 100: 495\u2013500.","DOI":"10.1136\/bjophthalmol-2015-306939"},{"key":"i1552-5783-60-5-1442-b28","doi-asserted-by":"crossref","unstructured":"Mejecase C, Laurent-Coriat C, Mayer C, et al. Identification of a novel homozygous nonsense mutation confirms the implication of GNAT1 in rod-cone dystrophy. PLoS One. 2016; 11: e0168271.","DOI":"10.1371\/journal.pone.0168271"},{"key":"i1552-5783-60-5-1442-b29","doi-asserted-by":"crossref","unstructured":"Wenzel A, Grimm C, Samardzija M, Reme CE. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res. 2005; 24: 275\u2013306.","DOI":"10.1016\/j.preteyeres.2004.08.002"},{"key":"i1552-5783-60-5-1442-b30","doi-asserted-by":"crossref","unstructured":"Hao W, Wenzel A, Obin MS, et al. Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat Genet. 2002; 32: 254\u2013260.","DOI":"10.1038\/ng984"},{"key":"i1552-5783-60-5-1442-b31","doi-asserted-by":"crossref","unstructured":"Krishnan J, Chen J, Shin K-J, et al. Gene expression profiling of light-induced retinal degeneration in phototransduction gene knockout mice. Exp Mol Med. 2008; 40: 495\u2013504.","DOI":"10.3858\/emm.2008.40.5.495"},{"key":"i1552-5783-60-5-1442-b32","doi-asserted-by":"crossref","unstructured":"Maeda A, Maeda T, Golczak M, et al. Involvement of all-trans-retinal in acute light-induced retinopathy of mice. J Biol Chem. 2009; 284: 15173\u201315183.","DOI":"10.1074\/jbc.M900322200"},{"key":"i1552-5783-60-5-1442-b33","doi-asserted-by":"crossref","unstructured":"Fan J, Sakurai K, Chen C-K, et al. Deletion of GRK1 causes retina degeneration through a transducin-independent mechanism. J Neurosci. 2010; 30: 2496\u20132503.","DOI":"10.1523\/JNEUROSCI.6254-09.2010"},{"key":"i1552-5783-60-5-1442-b34","doi-asserted-by":"crossref","unstructured":"Du J, Rountree A, Cleghorn WM, et al. Phototransduction influences metabolic flux and nucleotide metabolism in mouse retina. J Biol Chem. 2016; 291: 4698\u20134710.","DOI":"10.1074\/jbc.M115.698985"},{"key":"i1552-5783-60-5-1442-b35","doi-asserted-by":"crossref","unstructured":"Chen Y, Okano K, Maeda T, et al. Mechanism of all-trans-retinal toxicity with implications for Stargardt disease and age-related macular degeneration. J Biol Chem. 2012; 287: 5059\u20135069.","DOI":"10.1074\/jbc.M111.315432"},{"key":"i1552-5783-60-5-1442-b36","doi-asserted-by":"crossref","unstructured":"Xue Y, Shen SQ, Corbo JC, Kefalov VJ. Circadian and light-driven regulation of rod dark adaptation. Sci Rep. 2015; 5: 17616.","DOI":"10.1038\/srep17616"},{"key":"i1552-5783-60-5-1442-b37","doi-asserted-by":"crossref","unstructured":"Nivison-Smith L, O'Brien BJ, Truong M, Guo CX, Kalloniatis M, Acosta ML. Vinpocetine modulates metabolic activity and function during retinal ischemia. Am J Physiol Cell Physiol. 2015; 308: C737\u2013C749.","DOI":"10.1152\/ajpcell.00291.2014"},{"key":"i1552-5783-60-5-1442-b38","doi-asserted-by":"crossref","unstructured":"Bui BV, Kalloniatis M, Vingrys AJ. The contribution of glycolytic and oxidative pathways to retinal photoreceptor function. Invest Ophthalmol Vis Sci. 2003; 44: 2708\u20132715.","DOI":"10.1167\/iovs.02-1054"},{"key":"i1552-5783-60-5-1442-b39","doi-asserted-by":"crossref","unstructured":"Kohl S, Baumann B, Rosenberg T, et al. Mutations in the cone photoreceptor G-protein alpha-subunit gene GNAT2 in patients with achromatopsia. Am J Hum Genet. 2002; 71: 422\u2013425.","DOI":"10.1086\/341835"},{"key":"i1552-5783-60-5-1442-b40","doi-asserted-by":"crossref","unstructured":"Michaelides M, Aligianis IA, Holder GE, et al. Cone dystrophy phenotype associated with a frameshift mutation (M280fsX291) in the alpha-subunit of cone specific transducin (GNAT2). Br J Ophthalmol. 2003; 87: 1317\u20131320.","DOI":"10.1136\/bjo.87.11.1317"},{"key":"i1552-5783-60-5-1442-b41","doi-asserted-by":"crossref","unstructured":"Arundine M, Tymianski M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium. 2003; 34: 325\u2013337.","DOI":"10.1016\/S0143-4160(03)00141-6"},{"key":"i1552-5783-60-5-1442-b42","doi-asserted-by":"crossref","unstructured":"Wang H, Gong B, Vadakkan KI, Toyoda H, Kaang B-K, Zhuo M. Genetic evidence for adenylyl cyclase 1 as a target for preventing neuronal excitotoxicity mediated by N-methyl-D-aspartate receptors. J Biol Chem. 2007; 282: 1507\u20131517.","DOI":"10.1074\/jbc.M607291200"},{"key":"i1552-5783-60-5-1442-b43","doi-asserted-by":"crossref","unstructured":"Vighi E, Trifunovic D, Veiga-Crespo P, et al. Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration. Proc Natl Acad Sci U S A. 2018; 115: E2997\u2013E3006.","DOI":"10.1073\/pnas.1718792115"},{"key":"i1552-5783-60-5-1442-b44","doi-asserted-by":"crossref","unstructured":"Zeitz C, Robson AG, Audo I. Congenital stationary night blindness: an analysis and update of genotype-phenotype correlations and pathogenic mechanisms. Prog Retin Eye Res. 2015; 45: 58\u2013110.","DOI":"10.1016\/j.preteyeres.2014.09.001"},{"key":"i1552-5783-60-5-1442-b45","doi-asserted-by":"crossref","unstructured":"Sonoyama H, Shinoda K, Ishigami C, et al. Oguchi disease masked by retinitis pigmentosa. Doc Ophthalmol. 2011; 123: 127\u2013133.","DOI":"10.1007\/s10633-011-9286-x"},{"key":"i1552-5783-60-5-1442-b46","doi-asserted-by":"crossref","unstructured":"Nakamura M, Yamamoto S, Okada M, Ito S, Tano Y, Miyake Y. Novel mutations in the arrestin gene and associated clinical features in Japanese patients with Oguchi's disease. Ophthalmology. 2004; 111: 1410\u20131414.","DOI":"10.1016\/j.ophtha.2003.11.006"},{"key":"i1552-5783-60-5-1442-b47","doi-asserted-by":"crossref","unstructured":"Sullivan LS, Bowne SJ, Koboldt DC, et al. A novel dominant mutation in SAG, the Arrestin-1 gene, is a common cause of retinitis pigmentosa in hispanic families in the southwestern United States. Invest Ophthalmol Vis Sci. 2017; 58: 2774\u20132784.","DOI":"10.1167\/iovs.16-21341"},{"key":"i1552-5783-60-5-1442-b48","doi-asserted-by":"crossref","unstructured":"Sanyal S, Zeilmaker GH. Retinal damage by constant light in chimaeric mice: implications for the protective role of melanin. Exp Eye Res. 1988; 46: 731\u2013743.","DOI":"10.1016\/S0014-4835(88)80059-9"},{"key":"i1552-5783-60-5-1442-b49","doi-asserted-by":"crossref","unstructured":"Punzo C, Kornacker K, Cepko CL. Stimulation of the insulin\/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa. Nat Neurosci. 2009; 12: 44\u201352.","DOI":"10.1038\/nn.2234"},{"key":"i1552-5783-60-5-1442-b50","doi-asserted-by":"crossref","unstructured":"Bijveld MM, Florijn RJ, Bergen AAB, et al. Genotype and phenotype of 101 dutch patients with congenital stationary night blindness. Ophthalmology. 2013; 120: 2072\u20132081.","DOI":"10.1016\/j.ophtha.2013.03.002"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2730527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:03Z","timestamp":1791927063000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.19-26560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.19-26560","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,4]]}}}